Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

An international study led by MHH compares genomic data from national biobanks worldwide and identifies new risk factors in DNA that promote tumor development in the lining of the uterus.

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

Women with advanced form womb cancer have been given fresh hope after a new treatment was given the green light for ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention Schmandt RE, Iglesias DA, Co NN, Lu KH Am J Obstet Gynecol. 2011;205:518-525 ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...